Alterity Therapeutics

Alterity Therapeutics PRNAF Stock

$0.20   0.000000%
Add to favorites
Market Cap
$45.82M
LOW - HIGH [24H]
$0.20 - $0.20
VOLUME [24H]
$2.50K
P/E Ratio
0
Earnings per share
-$0.08
ISIN
AU0000043945

Alterity Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Alterity Therapeutics (PRNAF) stock price today is 0.2 USD on OTC Markets OTCPK (0% on the day). Updated .

Alterity Therapeutics PRNAF Financial and Trading Overview

Alterity Therapeutics stock price 0.2 USD
Previous Close 0.2 USD
Open 0.2 USD
Bid 0.15 USD x 500000
Ask 0.18 USD x 500000
Day's Range 0.2 - 0.2 USD
52 Week Range 0.0002 - 0.55 USD
Volume 2.5K USD
Avg. Volume 273 USD
Market Cap 45.82M USD
Beta (5Y Monthly) -0.023
PE Ratio (TTM) N/A
EPS (TTM) -0.08 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

PRNAF Valuation Measures

Enterprise Value 6.58M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 12.6925125
Price/Book (mrq) 1.4517324
Enterprise Value/Revenue 1.821
Enterprise Value/EBITDA -0.262

Trading Information

Alterity Therapeutics Stock Price History

Beta (5Y Monthly) -0.023
52-Week Change 2757.14%
S&P500 52-Week Change 12.07%
52 Week High 0.55 USD
52 Week Low 0.0002 USD
50-Day Moving Average 0.31 USD
200-Day Moving Average 0.16 USD

PRNAF Share Statistics

Avg. Volume (3 month) 273 USD
Avg. Daily Volume (10-Days) 1.25K USD
Shares Outstanding 229.1M
Float 173.12M
Short Ratio N/A
% Held by Insiders 8.69%
% Held by Institutions 17.98%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2026
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End June 30, 2027

Profitability

Profit Margin 0%
Operating Margin (ttm) -695.12%
Gross Margin 92.72%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -34.078%
Return on Equity (ttm) -54.97%

Income Statement

Revenue (ttm) 3.61M USD
Revenue Per Share (ttm) 0.02 USD
Quarterly Revenue Growth (yoy) -79.00000000000000000000000000000000%
Gross Profit (ttm) 3.35M USD
EBITDA -25090684 USD
Net Income Avi to Common (ttm) -23400948 USD
Diluted EPS (ttm) -0.08
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 37.32M USD
Total Cash Per Share (mrq) 0.17 USD
Total Debt (mrq) 193.47K USD
Total Debt/Equity (mrq) 0.45 USD
Current Ratio (mrq) 14.52
Book Value Per Share (mrq) 0.13776644

Cash Flow Statement

Operating Cash Flow (ttm) -22523332 USD
Levered Free Cash Flow (ttm) -14740514 USD

Profile of Alterity Therapeutics

Country United States
State VIC
City Melbourne
Address 500 Collins Street
ZIP 3000
Phone 61 3 9349 4906
Website https://alteritytx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 11

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Q&A For Alterity Therapeutics Stock

What is a current PRNAF stock price?

Alterity Therapeutics PRNAF stock price today per share is 0.2 USD.

How to purchase Alterity Therapeutics stock?

You can buy PRNAF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Alterity Therapeutics?

The stock symbol or ticker of Alterity Therapeutics is PRNAF.

Which industry does the Alterity Therapeutics company belong to?

The Alterity Therapeutics industry is Biotechnology.

How many shares does Alterity Therapeutics have in circulation?

The max supply of Alterity Therapeutics shares is 229.1M.

What is Alterity Therapeutics Price to Earnings Ratio (PE Ratio)?

Alterity Therapeutics PE Ratio is now.

What was Alterity Therapeutics earnings per share over the trailing 12 months (TTM)?

Alterity Therapeutics EPS is -0.08 USD over the trailing 12 months.

Which sector does the Alterity Therapeutics company belong to?

The Alterity Therapeutics sector is Healthcare.

$2.19T
Total marketcap
$71.54B
Total volume
BTC 58.24%   •   ETH 9.87%
Dominance
Select currency